Katherine E. Yanosick

机构：Beth Israel Deaconess Medical Center

发表论文 10 篇 · 总被引 860 次 · h-index 8

代表论文

• Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19 (2021 · JAMA · 被引 336)
• First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine (IPCAVD 001) (2012 · The Journal of Infectious Diseases · 被引 169)
• Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial (2022 · Nature Medicine · 被引 144)
• Safety and antiviral effect of a triple combination of HIV-1 broadly neutralizing antibodies: a phase 1/2a trial (2024 · Nature Medicine · 被引 61)
• Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial (2020 · The Lancet Infectious Diseases · 被引 58)
• First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector (2018 · The Journal of Infectious Diseases · 被引 45)